Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-12-22 Purchase |
2023-12-26 4:29 pm |
Elicio Therapeutics Inc. | ELTX | Chudnovsky Yekaterina GKCC LLC Director 10% Owner |
1,213,000 | $5.81 | $7,047,530 | 1,915,639 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-15 Option Award |
2025-04-16 5:12 pm |
N/A 2035-04-15 |
Elicio Therapeutics Inc. | ELTX | Shah Preetam See Remarks |
191,624 | $0 | 191,624 (Direct) |
View |
| 2025-03-05 Conversion |
2025-03-07 4:06 pm |
N/A N/A |
Elicio Therapeutics Inc. | ELTX | Chudnovsky Yekaterina GKCC LLC Director 10% Owner |
6,942,914 | $5.81 | 5,416,212 (Indirect) |
View |
| 2025-02-03 Option Award |
2025-02-04 4:11 pm |
N/A 2035-02-03 |
Elicio Therapeutics Inc. | ELTX | DeMuth Peter Chief Scientific Officer |
44,400 | $0 | 44,400 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-04 4:10 pm |
N/A 2035-02-03 |
Elicio Therapeutics Inc. | ELTX | Haqq Christopher See Remarks |
44,000 | $0 | 44,000 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-04 4:08 pm |
N/A 2035-02-03 |
Elicio Therapeutics Inc. | ELTX | Connelly Robert CEO, President and Director |
121,600 | $0 | 121,600 (Direct) |
View |
| 2024-12-16 Exercise |
2024-12-18 4:51 pm |
N/A N/A |
Elicio Therapeutics Inc. | ELTX | DeMuth Peter Chief Scientific Officer |
381 | $4.41 | 381 (Direct) |
View |
| 2024-12-16 Exercise |
2024-12-18 4:51 pm |
N/A 2024-12-18 |
Elicio Therapeutics Inc. | ELTX | DeMuth Peter Chief Scientific Officer |
381 | $0 | 381 (Direct) |
View |
| 2024-11-26 Exercise |
2024-11-29 07:39 am |
N/A N/A |
Elicio Therapeutics Inc. | ELTX | Venkatesan Jay Director |
50,000 | $0.01 | 180,534 (Direct) |
View |
| 2024-11-26 Exercise |
2024-11-29 07:39 am |
2024-07-01 N/A |
Elicio Therapeutics Inc. | ELTX | Venkatesan Jay Director |
50,000 | $0 | 180,534 (Direct) |
View |
| 2024-11-21 Option Award |
2024-11-25 4:05 pm |
N/A 2034-11-21 |
Elicio Therapeutics Inc. | ELTX | WILSON KAREN J Director |
4,100 | $0 | 4,100 (Direct) |
View |
| 2024-11-21 Option Award |
2024-11-25 07:37 am |
N/A 2034-11-21 |
Elicio Therapeutics Inc. | ELTX | ADAMS JULIAN Director |
4,100 | $0 | 4,100 (Direct) |
View |
| 2024-11-21 Option Award |
2024-11-25 07:36 am |
N/A 2034-11-21 |
Elicio Therapeutics Inc. | ELTX | Ashe Carol Gail Director |
4,100 | $0 | 4,100 (Direct) |
View |
| 2024-11-21 Option Award |
2024-11-25 07:35 am |
N/A 2034-11-21 |
Elicio Therapeutics Inc. | ELTX | Venkatesan Jay Director |
4,100 | $0 | 4,100 (Direct) |
View |
| 2024-11-21 Option Award |
2024-11-25 07:34 am |
N/A 2034-11-21 |
Elicio Therapeutics Inc. | ELTX | RUFFOLO ROBERT R Director |
4,100 | $0 | 4,100 (Direct) |
View |
| 2024-11-21 Option Award |
2024-11-25 07:33 am |
N/A 2034-11-21 |
Elicio Therapeutics Inc. | ELTX | Chudnovsky Yekaterina Director 10% Owner |
4,100 | $0 | 4,100 (Direct) |
View |
| 2024-11-21 Option Award |
2024-11-25 07:32 am |
N/A 2034-11-21 |
Elicio Therapeutics Inc. | ELTX | Nissenson Allen Director |
4,100 | $0 | 4,100 (Direct) |
View |
| 2024-09-30 Option Award |
2024-10-02 4:14 pm |
N/A 2034-09-30 |
Elicio Therapeutics Inc. | ELTX | Connelly Robert CEO, President and Director |
91,600 | $0 | 91,600 (Direct) |
View |
| 2024-09-30 Option Award |
2024-10-02 4:13 pm |
N/A 2024-09-30 |
Elicio Therapeutics Inc. | ELTX | DeMuth Peter Chief Scientific Officer |
29,800 | $0 | 29,800 (Direct) |
View |
| 2024-09-30 Option Award |
2024-10-02 4:12 pm |
N/A 2024-09-30 |
Elicio Therapeutics Inc. | ELTX | Haqq Christopher See Remarks |
28,200 | $0 | 28,200 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 06:01 am |
N/A 2034-02-01 |
Elicio Therapeutics Inc. | ELTX | Piekos Brian Chief Financial Officer |
43,225 | $0 | 43,225 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 06:01 am |
N/A 2034-02-01 |
Elicio Therapeutics Inc. | ELTX | Connelly Robert CEO, President and Director |
225,137 | $0 | 225,137 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 06:01 am |
N/A 2034-02-01 |
Elicio Therapeutics Inc. | ELTX | Haqq Christopher See Remarks |
28,200 | $0 | 28,200 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-05 06:01 am |
N/A 2034-02-01 |
Elicio Therapeutics Inc. | ELTX | DeMuth Peter Chief Scientific Officer |
30,142 | $0 | 30,142 (Direct) |
View |
| 2023-12-28 Option Award |
2023-12-29 5:05 pm |
N/A 2033-12-28 |
Elicio Therapeutics Inc. | ELTX | Nissenson Allen Director |
4,100 | $0 | 4,100 (Direct) |
View |
| 2023-12-28 Option Award |
2023-12-29 5:05 pm |
N/A 2033-12-28 |
Elicio Therapeutics Inc. | ELTX | Chudnovsky Yekaterina Director 10% Owner |
4,100 | $0 | 4,100 (Direct) |
View |
| 2023-12-28 Option Award |
2023-12-29 5:05 pm |
N/A 2033-12-28 |
Elicio Therapeutics Inc. | ELTX | WILSON KAREN J Director |
4,100 | $0 | 4,100 (Direct) |
View |
| 2023-12-28 Option Award |
2023-12-29 5:05 pm |
N/A 2033-12-28 |
Elicio Therapeutics Inc. | ELTX | ADAMS JULIAN Director |
4,100 | $0 | 4,100 (Direct) |
View |
| 2023-12-28 Option Award |
2023-12-29 5:05 pm |
N/A 2033-12-28 |
Elicio Therapeutics Inc. | ELTX | Venkatesan Jay Director |
4,100 | $0 | 4,100 (Direct) |
View |
| 2023-12-28 Option Award |
2023-12-29 5:05 pm |
N/A 2033-12-28 |
Elicio Therapeutics Inc. | ELTX | Ashe Carol Gail Director |
4,100 | $0 | 4,100 (Direct) |
View |
| 2023-12-28 Option Award |
2023-12-29 5:05 pm |
N/A 2033-12-28 |
Elicio Therapeutics Inc. | ELTX | RUFFOLO ROBERT R Director |
4,100 | $0 | 4,100 (Direct) |
View |
Ownership |
2023-06-12 5:14 pm |
N/A N/A |
Elicio Therapeutics Inc. | ELTX | Chudnovsky Yekaterina Director |
0 | $0 | 707,164 (Indirect) |
View |
Ownership |
2023-06-12 5:12 pm |
N/A N/A |
Elicio Therapeutics Inc. | ELTX | Haqq Christopher See Remarks |
0 | $0 | 135,492 (Direct) |
View |
Ownership |
2023-06-07 9:53 pm |
N/A 2027-12-27 |
Elicio Therapeutics Inc. | ELTX | DeMuth Peter Chief Scientific Officer |
0 | $0 | 90,299 (Direct) |
View |
Ownership |
2023-06-07 9:53 pm |
N/A 2032-12-06 |
Elicio Therapeutics Inc. | ELTX | Segal Assaf Director |
0 | $0 | 4,525 (Direct) |
View |
Ownership |
2023-06-07 9:48 pm |
N/A 2030-02-20 |
Elicio Therapeutics Inc. | ELTX | RUFFOLO ROBERT R Director |
0 | $0 | 17,078 (Direct) |
View |